A Study Exploring Olaparib And Temozolomide In Small Cell Lung Cancer

A Study Exploring Olaparib and Temozolomide in Small Cell Lung Cancer

Targeted Oncology

Dr. Farago on Combination of Olaparib and Temozolomide in Small Cell Lung Cancer

Olaparib and temozolomide for relapsed small cell lung cancer

Co-Clinical Trial of Olaparib and Temozolomide in SCLC PDX Models

Targeted Oncology

Small Cell Lung Cancer: Discovering New Metabolic Pathways

Children’s Research Institute at UT Southwestern

New Standard of care treatment for Small Cell lung cancer.

OncBrothers: Practice-Changing Cancer Discussions

Exploring novel therapeutic options for the treatments of small cell lung cancer (SCLC)

Exploring antibody-drug conjugates (ADCs) in lung cancer

DeLLphi-301 - FDA Approval of Tarlatamab in Patients w/ Prev Treated Small Cell Lung Cancer (SCLC)

OncBrothers: Practice-Changing Cancer Discussions

Dr. Maciej Michal Mrugala on the Efficacy and Further Uses of Temozolomide in Gliomas

Targeted Oncology

ADRIATIC study: New standard of care treatment for small cell lung cancer

OncBrothers: Practice-Changing Cancer Discussions

Novel Therapies In Small Cell Lung Cancer (SCLC): Lurbinectedin

GRACE - Global Resource for Advancing Cancer Education

Exploring the latest advances in first-line treatment of ES-SCLC

Touch Medical Media

Future developments in lobular carcinoma: targeting E-cadherin defects

Exploring Biomarkers for Immunotherapy Treatment in Lung Cancer

Targeted Oncology

Dr. Jane Robertson on the Mechanism of Action of Olaparib

Targeted Oncology

PIPSeN trial: Olaparib maintenance vs placebo in platinum-sensitive non-small cell lung cancer

S1 Episode 5: Small Cell Lung Cancer: What Are the First-line and Second-line Treatment Options?

Challenges in Treating Small Cell Lung Cancer

Targeted Oncology

Researchers discover new type of lung cancer

Cold Spring Harbor Laboratory